H.R. 8375 · 119th Congress · Health

Medicare Advantage Improvement Act of 2026

In committee6.1k words Introduced Apr 20, 2026 · Latest action Apr 27, 2026

How far it has goneStage 2 of 6
  1. IntroducedApr 20, 2026 Done
  2. CommitteeReferred to 2 committees Current stage
  3. House floorNot yet Not reached yet
  4. Senate floorNot yet Not reached yet
  5. Chambers agreeNot yet Not reached yet
  6. PresidentNot yet Not reached yet

What it does

The Congressional Research Service hasn’t published a summary of this bill. Read the full text on Congress.gov.

Who lobbies on it

15 organizations, more than 98% of House bills · 31 filings · Q2 2026–Q3 2026

These 15 organizations’ PACs gave $307K to 24 of the 25 members sponsoring or cosponsoring H.R. 8375 in the 2025–26 election cycle.

See who got it, from which PACs, and how they compare to the rest of the House → Pro

One square per quarter since introduction, oldest left. Filled = named it that quarter.

  1. American Medical Association 2 of 2 quarters
    “…H.R.8375 - Medicare Advantage Improvement Act of 2026, all provisions H.R.8500 - Timely Access to Coverage Decisions Act of 2026, all provisions H.R.8622 - Medicare Physician Data-driven Performance Payment System Act of 2026, all provisions H.R.879 - Medicare Patient Access and Practice Stabilization Act of 2025, all…”

    $17.6M lobbying spend in 2026 to date, all issuesQ3 2026 filing

  2. American Hospital Association 2 of 2 quarters
    “…H.R. 8375/ S. 4384, Medicare Advantage Improvement Act, all provisions; H.R. 8967 / S. 4460, Rural Community Hospital Demonstration Program Reauthorization, all provisions; H.R. 9468, Saving Today's Acute Care Resources (STAR) Act, all provisions; H.R. 8891, Rural Maternity Options for Medial Support (Rural MOMS) Act…”

    $14.4M lobbying spend in 2026 to date, all issuesQ3 2026 filing

  3. America's Health Insurance Plans Inc (ahip) 2 of 2 quarters
    “…H.R. 8375 - Medicare Advantage Improvement Act - Rep. Joyce, John - MA programmatic reforms H.R. 8377 - Stop Deadly Denials Act - Rep. Khanna, Ro - MA prior authorization prohibition H.R. 8875 - Improving Home Dialysis Act - Rep. Miller, Carol - Home dialysis coverage under Medicare H.R. 9542 - Protecting Health Care…”

    $11.3M lobbying spend in 2026 to date, all issuesQ3 2026 filing

12 more organizations, every filingPROUpgrade

Organizations that named H.R. 8375 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.

Actions

3 actions · newest first
  1. Apr 27, 2026Sponsor introductory remarks on measure. (CR H3095)
  2. Apr 20, 2026Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  3. Apr 20, 2026Introduced in House

What members said about it

  • Statement · Press release · Apr 23, 2026 · Joyce R-PA

    Dr. Joyce Introduces the Medicare Advantage Improvement Act (MAIA)

    Bipartisan Legislation Would Correct MA Administrative Barriers Washington, D.C. – This week, Congressman John Joyce, MD (PA-13), introduced H.R.8375, the Medicare Advantage Improvement Act (MAIA), bipartisan legislation aimed at…

    “Medicare is a promise to America’s seniors that they will have dependable access to quality healthcare in their later years. However, that promise has been undermined by unnecessary barriers to care—particularly through excessive use of prior authorization and inappropriate coverage denials in Medicare Advantage.”